virolog
began
ivanovski
paper
describ
retent
virul
leaf
sap
extract
crimean
tobacco
mosaic
leaf
diseas
lustig
levin
even
though
extract
sap
pass
bacteriaretain
filter
filtrat
retrain
abil
replic
within
live
plant
beijerinck
later
vinson
succeed
precipit
pathogen
tobacco
mosaic
diseas
experi
bawden
piri
reveal
pathogen
contain
rna
protein
compon
bawden
et
al
bawden
piri
experi
demonstr
genet
inform
store
rna
molecul
fraenkelconrat
et
al
later
concept
selfassembl
rna
coat
protein
cp
particl
establish
butler
klug
pathogen
known
tobacco
mosaic
viru
tmv
one
promin
virus
plant
molecular
pharm
tobacco
mosaic
viru
belong
tobamoviru
genu
posit
sens
singlestrand
genom
rna
grna
cap
terminu
dunigan
zaitlin
untransl
region
utr
harbor
transfer
rna
trna
like
structur
takamatsu
et
al
shown
figur
encod
total
four
protein
two
involv
rna
replic
plu
movement
protein
mp
cp
goelet
et
al
insid
plant
cell
grna
act
messeng
rna
mrna
templat
express
kda
protein
contain
methyltransferas
helicas
domain
plu
kda
readthrough
protein
contain
polymeras
domain
osman
buck
lewandowski
dawson
kda
kda
replic
protein
bind
termin
trnalik
structur
initi
transcript
complementari
negativesens
templat
lewandowski
dawson
osman
buck
negativesens
rna
act
templat
synthesi
fulllength
posit
strand
subgenom
rna
contain
mp
cp
open
read
frame
orf
ishikawa
et
al
mp
rna
bind
protein
involv
celltocel
spread
viru
citovski
et
al
chen
et
al
cp
enhanc
format
replic
complex
asurmendi
et
al
longdist
movement
saito
et
al
hilf
dawson
viral
particl
assembl
bloomer
et
al
butler
field
plant
molecular
pharm
born
franken
et
al
variou
pharmaceut
human
hormon
barta
et
al
antibodi
hiatt
et
al
vaccin
thanavala
et
al
produc
use
transgen
plant
current
sever
protein
manufactur
plant
commerci
bovin
trypsin
trypzean
express
maiz
commerci
sigmaaldrich
sigmaaldrich
corpor
unit
state
usda
approv
newcastl
diseas
viru
poultri
produc
tobacco
cellsuspens
dow
agrosci
vermij
waltz
fda
approv
taligluceras
alfa
manag
type
gaucher
diseas
produc
carrot
cell
protalix
biotherapeut
inc
maxmen
howev
gener
select
stabli
transform
plant
heterolog
protein
express
quit
elabor
timeconsum
lead
scientist
research
exploit
virus
purpos
plant
virus
tmv
takamatsu
et
al
cowpea
mosaic
viru
cpmv
gopinath
et
al
first
adapt
fullviru
vector
deconstructedviru
vector
recombin
protein
express
later
understood
viral
structur
capsid
assembl
nonenvelop
plant
virus
also
manipul
gener
chimer
viral
particl
nanoag
carriag
variou
compound
nanostructur
build
block
furthermor
recent
envelop
plant
virus
rhabdovirus
recov
agroinfiltr
cdna
ad
viral
particl
amend
lipid
envelop
arsen
avail
system
adopt
plant
virus
vector
transient
express
offer
mani
advantag
transgen
system
abil
applic
variou
plant
speci
hamamoto
et
al
reduc
genetoproduct
time
hendi
et
al
increas
yield
maclean
et
al
first
host
cell
infect
full
copi
plant
viru
either
dna
vitro
transcrib
rna
heterogen
sequenc
gene
interest
goi
clone
first
publish
virusbas
vector
genereplac
model
goi
replac
cp
brome
mosaic
viru
bmv
french
et
al
howev
lack
cp
recombin
viru
unabl
spread
infect
limit
inocul
cell
attempt
follow
use
tmvbase
vector
goi
insert
upstream
inher
cp
gene
control
addit
subgenom
rna
promot
inher
cp
subgenom
promot
duplic
dawson
et
al
still
design
unstabl
homolog
recombin
result
loss
insert
sequenc
revers
wildtyp
viru
dawson
et
al
third
approach
creat
hybrid
virusvector
contain
differ
subgenom
promot
sequenc
two
tobamovirus
tmv
odontoglossum
ringspot
viru
orsv
hybrid
design
result
stabl
vector
succeed
system
express
recombin
protein
donson
et
al
design
includ
fuse
recombin
protein
tmv
cp
either
ctermin
roder
et
al
ntermin
downstream
leaki
stop
codon
sugiyama
et
al
figur
show
describ
modif
approach
appli
tmv
tabl
list
number
plantmad
pharmaceut
protein
express
use
fullvir
vector
although
viral
vector
base
fullgenom
demonstr
success
produc
recombin
protein
construct
larg
insert
show
instabl
low
system
spread
shivprasad
et
al
avesani
et
al
togeth
biosafeti
concern
scholthof
et
al
limit
lead
develop
secondgener
vector
viru
genom
deconstruct
replicon
contain
essenti
viral
genom
compon
replic
gene
express
plantinfect
initi
exogen
system
viral
mp
andor
cp
gene
replac
recombin
goi
vector
introduc
plant
part
agrobacterium
deliv
tdna
gleba
et
al
biolist
bombard
komarova
et
al
chromosomeinsert
replicon
et
al
lack
cp
deconstructedviru
base
vector
lack
abil
encapsid
viral
particl
howev
retain
abil
replic
transcrib
translat
shown
figur
among
monopartit
rna
virus
potato
viru
x
pvx
komarova
et
al
tmv
lindbo
first
adopt
deconstructedviru
vector
deconstructedtmv
base
vector
commerci
pursu
icon
genet
magnifect
technolog
trademark
gleba
et
al
modif
includ
use
hybrid
rdrp
turnip
veinclear
viru
tvcv
arabidopsi
actin
promot
togeth
remov
cryptic
thyminerich
intron
site
plu
select
introduct
intron
marillonnet
et
al
magnifect
hybrid
tmvbase
vector
yield
gkg
fresh
weight
tissu
fwt
recombin
protein
gkg
fwt
full
immunoglobulin
g
igg
less
week
bendandi
et
al
similarli
deconstruct
viru
strategi
develop
bipartit
cpmv
earli
research
base
maintain
unmodifi
introduc
recombin
gene
construct
recombin
express
achiev
use
methodolog
fulllength
defect
version
code
plasmid
liu
et
al
surprisingli
vector
system
base
delet
region
achiev
higher
express
yield
obtain
fulllength
vector
sainsburi
et
al
experi
reveal
replic
base
molecul
essenti
high
yield
recombin
protein
express
still
achiev
absenc
sainsburi
et
al
modifi
mrna
hypertransl
provid
approxim
gkg
fwt
fulli
assembl
monoclon
antibodi
within
day
agroinfect
sainsburi
lomonossoff
tabl
list
number
plantmad
pharmaceut
protein
express
use
deconstructedvir
vector
cpmv
express
system
allow
eleg
extens
genomeintegr
cdna
amplifi
use
agroinfiltr
construct
cross
transgen
plant
et
al
method
induciblereplicon
system
dormant
viral
cassett
also
appli
tomato
mosaic
viru
tomv
system
suspensioncultur
plant
cell
dohi
et
al
applic
includ
develop
dormant
viral
cassett
activ
customchosen
stage
use
chemic
induc
ethanol
zhang
mason
via
creloxp
recombin
system
tremblay
et
al
plant
virus
first
exploit
biotechnolog
nonenvelop
consist
cp
subunit
abil
selfassembl
filament
structur
tmv
alonso
et
al
hollow
symmetr
icosahedr
structur
ccmv
zandi
et
al
shown
figur
b
better
understand
particl
architectur
biophys
properti
abil
manipul
genom
materi
virus
also
becam
exploit
viruslik
particl
vlp
selfassembl
structur
devoid
genom
materi
huang
et
al
develop
virusbas
nanoparticl
vnp
steinmetz
et
al
instanc
detail
molecular
structur
knowledg
filament
virus
tmv
namba
et
al
pvx
parker
et
al
tvcv
lartey
et
al
papmv
yang
et
al
permit
use
variou
applic
vaccin
smolenska
et
al
petukhova
et
al
therien
et
al
fluoresc
marker
yi
et
al
biocatalyst
carett
et
al
nanoparticl
biolog
purif
werner
et
al
nanoparticl
vivo
imag
niehl
et
al
assembl
unit
memori
devic
tseng
et
al
shown
figur
nonenvelop
plant
virus
engin
three
differ
way
modif
outer
capsid
whether
genet
manipul
chemic
modif
capsid
amino
acid
moieti
combin
incorpor
heterolog
cargo
inner
caviti
particl
integr
multival
structur
tabl
provid
exampl
current
vnp
develop
agent
use
gene
deliveri
azizgolshani
et
al
chemotherapi
et
al
immunotherapi
venuti
et
al
vaccin
phelp
et
al
plant
virusassist
sensor
review
eiben
et
al
product
plant
viru
base
vlp
vaccin
receiv
attent
sinc
earli
usha
et
al
plant
rna
virus
tmv
koo
et
al
cpmv
mclain
et
al
cmv
nuzzaci
et
al
plum
pox
potyviru
ppv
et
al
potato
viru
x
pvx
lico
et
al
tomato
bushi
stunt
viru
tbsv
joelson
et
al
adapt
product
vaccin
test
variou
anim
model
studi
conduct
biodistribut
clearanc
tmv
bruckman
et
al
pvx
tomato
bushi
stunt
viru
tbsv
blandino
et
al
anim
model
show
vlp
induc
patholog
damag
plant
virus
pathogen
mammal
recogn
pathogen
associ
molecular
pattern
pamp
receptor
innat
immun
system
et
al
shown
elicit
humor
respons
administ
parenter
brennan
et
al
mucos
rout
brennan
et
al
cell
mediat
respons
yusibov
et
al
kemnad
et
al
instanc
vlp
induc
murin
antibodi
recogn
influenzainfect
cell
provid
protect
deni
et
al
without
papmv
vlp
induc
cellular
toxic
rioux
et
al
product
plant
viru
base
vlp
limit
plant
varieti
heterolog
system
insect
cell
lamb
et
al
yeast
brumfield
et
al
escherichia
coli
deni
et
al
employ
produc
recombin
potato
leafrol
viru
plrv
ccmv
papmv
cp
assembl
viral
particl
indistinguish
plant
produc
counterpart
nevertheless
plantproduc
vlp
remain
econom
choic
plant
product
scalabl
costeffect
product
cost
lower
e
coli
eukaryoticbas
system
kusnadi
et
al
et
al
substanti
safeti
advantag
compar
mammaliancel
produc
altern
et
al
last
decad
vlp
extens
develop
recombin
vaccin
differ
system
whether
plant
mammalian
souli
et
al
insect
le
tallec
et
al
yeast
agnandji
et
al
e
coli
fier
et
al
proven
immunogen
current
avail
market
hepat
b
viru
hbv
keat
nobl
human
papillomaviru
hpv
szarewski
produc
glaxosmithklin
respect
equival
recombivax
venter
et
al
tomljenov
shaw
produc
merck
nevertheless
produc
vlp
whether
genet
fusion
chemic
conjug
remain
challeng
especi
complex
multimer
antigen
jagu
et
al
benen
et
al
full
length
glycoprotein
adopt
differ
conform
kwong
et
al
cullen
et
al
larg
epitop
werner
et
al
termini
involv
protein
fold
pejawargaddi
et
al
might
interrupt
capsid
synchron
assembl
zlotnick
et
al
postexpress
chemic
conjug
drawback
increas
downstream
process
cost
buonaguro
butlerransohoff
wilken
nikolov
sabalza
et
al
buyel
et
al
furthermor
chimer
vlp
express
recombin
peptid
found
induc
reduc
neutral
antibodi
titr
compar
full
domain
vaccin
gedvilait
et
al
even
among
plantviru
base
vlp
instanc
alfalfa
mosaic
virusbas
plasmodium
falciparum
vlp
although
shown
induc
p
falciparum
block
antibodi
mice
jone
et
al
phase
clinic
trial
shown
provid
low
protect
level
chichest
et
al
line
difficulti
limit
consid
encount
envelop
vlp
evlp
grow
trend
toward
use
evlp
product
platform
gheysen
et
al
system
structur
viral
protein
express
incorpor
host
membran
releas
particl
envelop
provid
flexibl
integr
complet
envelopeprotein
glycoprotein
resembl
nativ
viru
yamshchikov
et
al
baumert
et
al
latham
galarza
along
idea
attempt
made
produc
variou
evlp
vaccin
purpos
eg
influenza
viru
product
evlp
insect
cell
express
influenza
viru
structur
protein
khurana
et
al
hiv
base
virosom
vitro
associatedspik
peptid
lerouxroel
et
al
breast
cancer
base
vitro
associ
antigen
peptid
synthes
phospholipid
membran
wiedermann
et
al
influenza
evlp
produc
coexpress
two
major
antigen
envelop
protein
hemagglutinin
ha
neuraminidas
na
plu
matrix
pushko
et
al
coexpress
ha
enabl
bud
galarza
et
al
attempt
perform
anim
cell
system
recent
plant
also
use
platform
produc
evlp
avian
influenza
landri
et
al
habas
influenza
vlp
found
bud
plasma
membran
plant
cell
express
ha
without
need
viral
protein
aoust
et
al
due
absenc
glycoprotein
sialyl
plant
et
al
moreov
importantli
plantproduc
ha
base
evlp
vaccin
found
elicit
durabl
crossreact
cell
respons
current
undergo
clinic
trial
medicago
landri
et
al
find
support
strengthen
develop
exploit
envelop
plant
virusbas
vector
system
amen
genet
manipul
plant
molecular
pharm
plant
virus
exist
natur
occur
envelop
classifi
within
order
bunyaviral
mononegaviral
famili
rhabdovirida
neg
strand
rna
genom
king
et
al
consid
monopartit
rhabdovirus
easier
handl
revers
genet
system
recent
establish
plant
infect
rhabdoviru
present
attract
platform
develop
pseudotyp
viralvaccin
upon
inher
envelop
provid
need
flexibl
incorpor
larg
complex
antigen
theoret
model
explain
rhabdoviru
transcript
replic
built
upon
experi
mammalian
rhabdovirus
one
well
studi
vesicular
stomat
viru
vsv
emerson
wertz
et
al
ribonucleoprotein
rnp
unit
consist
viral
rna
associ
n
l
p
protein
act
templat
viral
transcript
replic
yang
et
al
kawai
et
al
virionassoci
l
protein
transcrib
nc
mrna
distinct
protein
moyer
banerje
toriyama
peter
transcript
direct
gradient
follow
order
gene
viru
genom
control
untransl
leader
sequenc
emerson
nontransl
intergenom
region
respect
shown
figur
barr
et
al
fink
et
al
transcript
viral
gene
result
gener
monocistron
polyadenyl
mrna
later
infect
np
complex
inhibit
transcript
switch
function
l
protein
transcript
replic
la
ferla
peluso
gupta
banerje
first
grna
replic
antigenom
sens
rna
agrna
templat
full
positivesens
rna
without
cap
poli
tail
encapsid
n
protein
arnheit
et
al
zhang
et
al
later
agrna
function
templat
progeni
negativesens
grna
albertini
et
al
ivanov
et
al
progeni
grna
assembl
rnp
protein
convert
extend
helic
rnp
condens
form
kaptur
et
al
result
bulletshap
morpholog
rhabdovirus
mebats
et
al
final
g
protein
tail
incorpor
assembl
mrnp
complex
aid
bud
progeni
viru
particl
whitt
et
al
schnell
et
al
initi
attempt
gener
rhabdovirus
cdna
base
mammalian
rhabdovirus
research
vsv
reveal
genom
rna
must
encapsid
viral
n
protein
function
templat
rnadepend
rna
polymeras
emerson
wagner
discoveri
follow
set
experi
enabl
first
rescu
revers
genet
system
vsv
defect
interf
di
particl
cell
cotransfect
five
canon
protein
pattnaik
wertz
research
rabi
viru
rabv
demonstr
express
report
gene
clone
viral
termini
cell
cotransfect
plasmid
encod
three
helper
protein
n
p
l
conzelmann
schnell
find
follow
recoveri
infecti
envelop
rabi
viru
particl
cdna
schnell
et
al
similarli
strategi
subsequ
use
rescu
vertebr
rhabdovirus
vsv
whelan
et
al
snakehead
rhabdoviru
shrv
johnson
et
al
infecti
haematopoiet
necrosi
viru
iihnv
haemorrhag
septicaemia
viru
vhsv
kim
et
al
similar
attempt
reconstitut
plant
rhabdoviru
start
jackson
laboratori
n
benthamiana
cellulosedigest
protoplast
found
suitabl
studi
sonchu
yellow
net
viru
synv
replic
jone
jackson
howev
real
challeng
codeliveri
plasmid
need
recoveri
recombin
virus
singl
cell
difficulti
circumv
use
agrobacterium
infiltr
codeliv
vector
express
synv
helper
protein
n
benthamiana
leav
goodin
et
al
group
demonstr
success
first
plant
rhabdoviru
synv
minireplicon
mr
strategi
ganesan
et
al
plasmid
harbor
positivesens
mr
cassett
contain
two
sequenti
clone
report
gene
synv
termini
togeth
synv
helper
protein
coinfiltr
n
benthamiana
fluoresc
signal
detect
day
postinfiltr
restrict
singl
cell
promis
success
culmin
infecti
synv
recov
upper
leav
n
benthamiana
plant
agroinfiltr
four
plasmid
harbor
positivesens
synv
cdna
togeth
helper
protein
plasmid
wang
et
al
mention
earlier
mammalian
rhabdovirus
particular
vesicular
stomat
viru
vsv
remain
prototyp
revers
engin
molecular
adapt
rhabdovirus
like
rhabdovirus
canon
n
p
g
l
gene
neg
sens
singl
strand
rna
genom
figur
vsv
success
rescu
cdna
whelan
et
al
first
engin
express
report
gene
place
viral
glycoprotein
polymeras
schnell
et
al
later
year
recombin
vsv
rvsv
success
produc
incorpor
foreign
protein
addit
vsv
inher
glycoprotein
viral
envelop
schnell
et
al
recombin
vsv
particl
two
design
consid
first
full
foreign
protein
incorpor
vsv
envelop
figur
second
exoplasm
domain
foreign
protein
fuse
upstream
transmembran
domain
cytoplasm
tail
vsv
glycoprotein
figur
furthermor
recombin
vsv
lack
inher
glycoprotein
express
receptor
infect
kill
infect
tcell
success
rescu
schnell
et
al
figur
abil
rescu
vsv
without
inher
g
protein
gave
opportun
gener
safer
nonpropag
vsv
base
vaccin
robert
et
al
moreov
attenu
strategi
base
malleabl
rhabdoviru
genom
strategi
decreas
express
level
viral
gene
manipul
posit
express
gradient
flanagan
et
al
g
gene
truncat
n
gene
transloc
clark
et
al
also
consid
instanc
insert
foreign
gene
upstream
vsv
n
gene
figur
insert
foreign
gene
upstream
n
gene
reloc
n
gene
downstream
gene
truncat
vsv
g
protein
figur
also
adapt
rescu
recombin
vsv
base
vaccin
cooper
et
al
inher
genom
characterist
rhabdovirus
welldefin
transcript
startstop
signal
stillman
whitt
abil
accommod
larg
insert
retain
high
level
express
rate
haglund
et
al
togeth
neglig
seroposit
human
popul
robert
et
al
made
vsv
lucr
candid
vaccin
develop
vector
number
biomed
applic
recombin
viral
vaccin
safronetz
et
al
lauretti
et
al
gene
deliveri
vector
beier
et
al
oncolyt
vector
bridl
et
al
exemplifi
tabl
current
number
ongo
clinic
trial
base
phase
iii
clinic
trial
vsv
base
ebola
viru
vaccin
rvsvzebov
huttner
et
al
nowaday
vsv
commonli
consid
success
wide
use
platform
heterolog
express
complex
interest
pharmaceut
biomolecul
gener
pseudo
type
evlp
vaccin
purpos
expect
avail
exploit
envelop
plant
virus
biolog
particl
analog
vsv
give
boost
exploit
plantbas
product
platform
complex
glyco
protein
plant
molecular
pharm
materi
reliabl
costeffect
platform
product
pharmaceut
vaccin
biobett
product
number
plantproduc
protein
start
commerci
ratner
yusibov
et
al
simultan
develop
viral
vector
togeth
agroinfect
culmin
rapid
transient
express
system
success
express
high
level
larg
complex
pharmaceut
protein
antimicrobi
peptid
fischer
eman
chen
et
al
peyret
lomonossoff
loh
et
al
leit
et
al
enabl
product
plantviru
base
vlp
chronic
infecti
diseas
hefferon
sahithi
et
al
howev
compar
system
counterpart
plantviru
base
vlp
inher
constrain
abil
present
complex
antigen
glycoprotein
moreov
case
rapidli
evolv
virus
influenza
select
pressur
drive
viral
evas
immun
respons
induc
vlp
vaccin
base
amino
acid
antigen
reproduc
nativ
conform
epitop
furthermor
attempt
produc
plantmad
evlp
influenza
ha
vlp
far
proven
success
inher
characterist
influenza
viru
ha
eas
detach
evlp
plant
cell
surfac
aoust
et
al
basi
success
necessari
applic
case
therefor
develop
revers
engin
inher
envelop
plantvirus
rhabdovirus
expect
give
plant
molecular
pharm
platform
wide
rang
biotechnolog
applic
relev
express
envelop
vlp
expos
chimer
complex
antigen
consid
vsv
prototyp
inher
rhabdoviru
characterist
envelop
defin
genom
transcript
unit
schnell
et
al
genom
stabil
walker
et
al
abil
stabli
incorpor
recombin
glycoprotein
envelop
schnell
et
al
make
ideal
variou
biotechnolog
applic
plant
rhabdovirus
share
inher
characterist
togeth
dispens
g
protein
system
plantinfect
demonstr
snyv
wang
et
al
g
protein
requir
viru
entri
subsequ
propag
within
arthropod
vector
hogenhout
et
al
carboxyltermin
domain
g
protein
togeth
protein
requir
morphogenesi
bud
envelop
particl
sun
et
al
henc
addit
characterist
enabl
larg
scale
product
recombin
rhabdoviru
base
evlp
expos
ectodomain
g
exchang
anoth
geneofinterest
goi
glycoprotein
chimer
virus
contain
within
plant
requir
less
stringent
contain
control
similarli
vsvrecombin
design
plant
rhabdoviru
vector
construct
also
construct
contain
goi
differ
gene
posit
variou
express
purpos
figur
advantag
togeth
establish
plant
molecular
pharm
cost
effect
reliabl
product
platform
make
plant
rhabdovirus
promis
candid
biotechnolog
gener
field
plantmad
recombin
viral
vaccin
specif
ai
wrote
first
draft
manuscript
ai
vo
rk
contribut
manuscript
revis
also
read
approv
submit
version
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
